L'Occitane International S.A. (0973.HK)
HKD 33.8
(0.3%)
HKD 33.8
(0.3%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 736.64 Million EUR | 13.8% |
| 2022 | 647.3 Million EUR | 10.79% |
| 2021 | 584.26 Million EUR | 47.68% |
| 2020 | 395.62 Million EUR | -45.83% |
| 2019 | 730.34 Million EUR | 62.88% |
| 2018 | 448.4 Million EUR | 258.34% |
| 2017 | -283.18 Million EUR | 22.43% |
| 2016 | -365.05 Million EUR | -13.48% |
| 2015 | -321.69 Million EUR | -17.99% |
| 2014 | -272.64 Million EUR | -17.94% |
| 2013 | -231.16 Million EUR | -0.84% |
| 2012 | -229.23 Million EUR | 0.62% |
| 2011 | -230.65 Million EUR | 1.53% |
| 2010 | -234.23 Million EUR | -1016.84% |
| 2009 | 25.54 Million EUR | -70.58% |
| 2008 | 86.83 Million EUR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q1 | 603.91 Million EUR | -6.7% |
| 2023 Q3 | 647.63 Million EUR | -6.02% |
| 2023 Q4 | 736.64 Million EUR | 13.75% |
| 2023 Q2 | 689.12 Million EUR | 14.11% |
| 2023 FY | 736.64 Million EUR | 13.8% |
| 2022 Q1 | 637.89 Million EUR | 9.18% |
| 2022 FY | 647.3 Million EUR | 10.79% |
| 2022 Q4 | 647.3 Million EUR | 14.59% |
| 2022 Q3 | 564.91 Million EUR | -22.19% |
| 2022 Q2 | 725.97 Million EUR | 13.81% |
| 2021 Q4 | 584.26 Million EUR | 19.11% |
| 2021 Q3 | 490.54 Million EUR | -2.24% |
| 2021 FY | 584.26 Million EUR | 47.68% |
| 2021 Q2 | 501.78 Million EUR | 22.35% |
| 2021 Q1 | 410.12 Million EUR | 3.66% |
| 2020 Q4 | 395.62 Million EUR | 24.75% |
| 2020 Q2 | 666.11 Million EUR | 17.18% |
| 2020 Q3 | 317.14 Million EUR | -52.39% |
| 2020 FY | 395.62 Million EUR | -45.83% |
| 2020 Q1 | 568.44 Million EUR | -22.17% |
| 2019 Q2 | 862.03 Million EUR | 13.63% |
| 2019 Q4 | 730.34 Million EUR | 15.72% |
| 2019 FY | 730.34 Million EUR | 62.88% |
| 2019 Q1 | 758.66 Million EUR | 69.19% |
| 2019 Q3 | 631.13 Million EUR | -26.79% |
| 2018 Q3 | 432.29 Million EUR | 324.06% |
| 2018 FY | 448.4 Million EUR | 258.34% |
| 2018 Q4 | 448.4 Million EUR | 3.73% |
| 2018 Q2 | -192.93 Million EUR | 7.91% |
| 2018 Q1 | -209.51 Million EUR | 26.01% |
| 2017 Q2 | -199.41 Million EUR | 7.22% |
| 2017 Q1 | -214.92 Million EUR | 41.12% |
| 2017 FY | -283.18 Million EUR | 22.43% |
| 2017 Q3 | -299.27 Million EUR | -50.08% |
| 2017 Q4 | -283.18 Million EUR | 5.37% |
| 2016 Q3 | -381.35 Million EUR | -33.42% |
| 2016 FY | -365.05 Million EUR | -13.48% |
| 2016 Q1 | -301.48 Million EUR | 6.28% |
| 2016 Q2 | -285.82 Million EUR | 5.19% |
| 2016 Q4 | -365.05 Million EUR | 4.28% |
| 2015 Q2 | -275.26 Million EUR | 5.08% |
| 2015 Q3 | -337.58 Million EUR | -22.64% |
| 2015 Q4 | -321.69 Million EUR | 4.71% |
| 2015 FY | -321.69 Million EUR | -17.99% |
| 2015 Q1 | -289.99 Million EUR | -6.36% |
| 2014 Q2 | -170.98 Million EUR | 6.74% |
| 2014 FY | -272.64 Million EUR | -17.94% |
| 2014 Q4 | -272.64 Million EUR | 4.95% |
| 2014 Q3 | -286.85 Million EUR | -67.77% |
| 2014 Q1 | -183.34 Million EUR | 20.69% |
| 2013 Q4 | -231.16 Million EUR | 4.4% |
| 2013 Q2 | -190.34 Million EUR | 4.87% |
| 2013 Q1 | -200.09 Million EUR | 12.71% |
| 2013 FY | -231.16 Million EUR | -0.84% |
| 2013 Q3 | -241.8 Million EUR | -27.04% |
| 2012 FY | -229.23 Million EUR | 0.62% |
| 2012 Q1 | -292.02 Million EUR | -26.61% |
| 2012 Q3 | -239.01 Million EUR | -17.73% |
| 2012 Q4 | -229.23 Million EUR | 4.09% |
| 2012 Q2 | -203.01 Million EUR | 30.48% |
| 2011 Q4 | -230.65 Million EUR | 0.0% |
| 2011 FY | -230.65 Million EUR | 1.53% |
| 2011 Q2 | -168.09 Million EUR | 0.0% |
| 2010 Q2 | -182.54 Million EUR | 0.0% |
| 2010 Q4 | -234.23 Million EUR | 0.0% |
| 2010 FY | -234.23 Million EUR | -1016.84% |
| 2009 Q4 | 25.54 Million EUR | 0.0% |
| 2009 FY | 25.54 Million EUR | -70.58% |
| 2008 FY | 86.83 Million EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Natural Beauty Bio-Technology Limited | 27.54 Million HKD | -2574.441% |
| Innovative Pharmaceutical Biotech Limited | 914.37 Million HKD | 19.437% |
| China Overseas Nuoxin International Holdings Limited | 9.99 Million HKD | -7273.116% |
| Prosperous Future Holdings Limited | -337.41 Million HKD | 318.32% |
| Huasheng International Holding Limited | 175.03 Million HKD | -320.853% |
| Fourace Industries Group Holdings Limited | -250.33 Million HKD | 394.267% |
| Evergreen Products Group Limited | 430.83 Million HKD | -70.981% |
| EC Healthcare | 1.05 Billion HKD | 29.848% |
| Ming Fai International Holdings Limited | -329.49 Million HKD | 323.572% |
| Blue Moon Group Holdings Limited | -4.18 Billion HKD | 117.608% |
| SuperRobotics Holdings Limited | 126.44 Million HKD | -482.602% |
| Takbo Group Holdings Limited | -175.44 Million HKD | 519.886% |
| Hyfusin Group Holdings Limited | -318.4 Million HKD | 331.353% |